Your browser doesn't support javascript.
loading
[Quality management of the experimental health products circuit in hospital pharmacies: National inventory and proposed standardised tools]. / Management de la qualité du circuit des produits de santé expérimentaux dans les pharmacies hospitalières : enquête nationale et développement d'outils standardisés.
Delavoipière, E; Bouglé, C; Saint-Lorant, G; Divanon, F; Alix, A.
Afiliación
  • Delavoipière E; Service de pharmacie, centre de lutte contre le cancer François-Baclesse, 3, avenue Général-Harris, BP 45026, 14076 Caen cedex 5, France. Electronic address: e.delavoipiere@baclesse.unicancer.fr.
  • Bouglé C; Observatoire du médicament, des dispositifs médicaux et des innovations thérapeutiques de Normandie, espace Claude-Monet Basse-Normandie, 2, place Jean-Nouzille, 14000 Caen, France.
  • Saint-Lorant G; Service de pharmacie, CHU de Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France.
  • Divanon F; Service de pharmacie, centre de lutte contre le cancer François-Baclesse, 3, avenue Général-Harris, BP 45026, 14076 Caen cedex 5, France.
  • Alix A; Service de pharmacie, CHU de Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France.
Ann Pharm Fr ; 80(5): 758-768, 2022 Sep.
Article en Fr | MEDLINE | ID: mdl-34896379
OBJECTIVES: Carry out a national inventory of the current situation regarding the quality management of the investigational health products circuit, to develop adapted standardised tools. METHODS: A survey of 76 questions, developed by a regional working group, was conducted among clinical research pharmacists in French facilities. Tools were developed to meet the identified needs and validated by participating pharmacists, using the Delphi method. The consensus was defined by achieving a score above 80% on relevance, clarity and evaluability. RESULTS: Among 94 pharmacists participating in the survey, 88 were interested in standardised tools. The score for the implementation of a quality approach depended on the type of health facility (P<0.0005) and increased with the number of active trials (P<0.0005). All nine proposed tools were useful for over two thirds of pharmacists, but the self-assessment and audit grids have been prioritised. Indeed, only 26% of pharmacies carried out a prior risk assessment and 14% carried out internal audits. The review of both grids led to a consensus on 89% and 97% of the criteria respectively. The validated grids include 62 and 72 criteria respectively. DISCUSSION: The quality approach of the investigational health products circuit is heterogeneous in the participating centres, with a strong need for standardised tools. The two grids are relevant tools developed by and for professionals. CONCLUSION: The tools developed will enable to optimise the quality approach by identifying the non-conformities of the investigational health products circuit.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: Fr Revista: Ann Pharm Fr Año: 2022 Tipo del documento: Article Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: Fr Revista: Ann Pharm Fr Año: 2022 Tipo del documento: Article Pais de publicación: Francia